Back to Trades
Smith Karen L.
DirectorCIK 0001639637
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 2
- Active
- 2026
Smith Karen L., Director, has filed 3 SEC reports (2026), spread across 2 companies, totaling $100.7K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jun 26 | CNTX Context Therapeutics Inc. | Smith Karen L. | Director | Award | $25.9K |
| Apr 2 | SKYE Skye Bioscience, Inc. | Smith Karen L. | Director | Award | $46.1K |
| Feb 9 | SKYE Skye Bioscience, Inc. | Smith Karen L. | Director | Award | $28.7K |
3 filings